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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
1. To assess the effects of dance movement therapy (DMT) for depression compared with no treatment (waiting list) or to standard
care in both child and adult populations
2. To compare DMT with other psychological interventions (e.g. psychodynamic psychotherapy or IPT, counselling or CBT)
3. To compare DMT with pharmacological interventions (e.g. anti-depressants, minor tranquillisers or mood stabilisers)
4. To compare DMT with other physical interventions (e.g. dance or exercise)
5. To compare different forms of DMT (e.g. Laban-based DMT, Chacian DMT or Authentic Movement) (see below for
explanations of these)
B A C K G R O U N D
Description of the condition
Depression is characterised by low mood, a loss of interest or plea-
sure in most activities, sleep disturbances (either lack of sleep or
over sleeping), changes in appetite or unintentional changes of
weight (up or down), decreased energy, either slowed or agitated
movement, decreased concentration and, in some cases, feelings
of guilt, worthlessness and potentially thoughts of suicide (APA
2000). The diagnosis of major depression requires five or more of
these symptoms, including depressed mood or a loss of interest
or pleasure in most activities, which have been present during the
same two-week period and cause significant distress or impairment
of functioning (Williams 2002). Depression is a prevalent condi-
tion; the World Health Organization (WHO 2010a) reports that
it affects about 121 million people worldwide. In the UK, 60% of
the population meet the criteria for major depressive disorder or
dysthymia (chronic depression which is less severe than major de-
pression) at any time, with 20% of major depressive disorders per-
sisting more than two years, 30% relapsing within three months
of recovery and 50% within two years (Scott 2003). Depression
thus represents a significant burden to families and to society. It
has a negative impact on quality of life and can lead to suicide
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(Scott 2003). Often depression remains undiagnosed, which sug-
gests that the real scale of the problem is probably much larger.
Description of the intervention
The two key strategies used to treat depression, and often used in
combination, are talking therapies (for example counselling, psy-
chodynamic psychotherapy, interpersonal therapy or cognitive be-
havioural therapy) and pharmacological treatments such as: anti-
depressants (including Serotonin Selective Re-uptake Inhibitors
(SSRIs), Tricyclics, Monoamine Oxidase Inhibitors (MAOIs) and
Serontonin and Noradrenaline Re-uptake Inhibitors (SNRIs));
and mood stabilisers including Lithium. Physical activity is also
recommended as a low intensity intervention (NICE 2010). A
Cochrane systematic review (Moncrieff 2004) found only small
differences between the effects of anti-depressant medication and
active placebos. Disadvantages to pharmacological treatments are
that they may have adverse side effects, adherence can be poor,
and there is a lag time between starting treatment and any clinical
improvement (Pampallona 2002).
A Cochrane systematic review of psychosocial and psychological
treatments for postpartum depression (Dennis 2007a) found that
any psychosocial or psychological intervention, when compared
with usual postpartum care, was associated with a reduction in
depression within the first year postpartum. While there is some
evidence that interpersonal therapy (IPT) may be superior to a
parenting education programme in treating antenatal depression,
the evidence remains inconclusive (Dennis 2007b). Family ther-
apy (Henken 2007) and marital therapy (Barbato 2006) have also
both been reviewed as treatments of depression, but no significant
advantage was found with either of these treatments over other
psychological or pharmacological treatments. A Cochrane system-
atic review of psychological treatments for older people (Wilson
2008) concluded that cognitive behavioural therapy (CBT) may
be of benefit, although there was no significant difference in treat-
ment effect between psychodynamic therapy andCBT in the three
trials reviewed.
As far as physical activity is concerned, a meta-analysis completed
in 1998 (Craft 1998) testifies that there is evidence for benefi-
cial effects of exercise on depressive symptoms. More recently, a
Cochrane review by Mead 2010 indicated that there is evidence
of positive effects of group exercise. As a result, physical activity
is now recommended by the NICE guideline for adult depres-
sion (NICE 2010). However, Mead 2010 highlights that research
studies to date have not revealed the type of exercise that is most
suitable for this client population. They also note that so far stud-
ies concerning exercise have been hampered by methodological
problems and a lack of follow-up studies.
Furthermore, it appears that the most readily available treatments
may not be suitable for everyone, either for reasons of side-effects,
cost or personal preference. Arts therapies (that is art therapy,
dance movement therapy, dramatherapy and music therapy) are
less common treatment options for people faced with depression,
and scientific evidence for their effectiveness remains limited. The
only available Cochrane systematic review of arts therapies for
this population has been in music therapy (Maratos 2008). The
review concluded that music therapy is an acceptable treatment
and is associated with improvements in mood, however there was
insufficient evidence to be able to establish effectiveness.
Dance movement therapy (DMT) is another arts therapy disci-
pline which has reported evidence of effectiveness. For example, a
meta-analysis completed by Ritter 1996 and recalculated by Cruz
1998 provides evidence for mild to moderate effect size of DMT
for a wide range of different client groups and for an array of
symptoms including reduction of symptoms of anxiety and de-
pression. As DMT combines the benefits of mild physical activity
with psychological therapy, it may open up the options within
non-pharmaceutical therapy to people with depressionwho do not
feel able or do not wish to focus exclusively on talking about their
problems, or who prefer non-medical approaches to treatment as
identified in the 2010 NICE guideline (NICE 2010).
DMT is also known as dance therapy, movement therapy, dance
movement psychotherapy, movement psychotherapy, dance/
movement therapy or dance-movement therapy. One of the defi-
nitions found in the field is as follows.
“Dance Movement (Psycho)therapy is the psychotherapeutic use
of movement and dance through which a person can engage cre-
atively in a process to further their emotional, cognitive, phys-
ical and social integration. It is founded on the principle that
movement reflects an individual’s patterns of thinking and feeling.
Through acknowledging and supporting clients’ movements, the
therapist encourages development and integration of new adap-
tive movement patterns together with the emotional experiences
that accompany such changes” (Association for Dance Movement
Psychotherapy UK) (ADMP UK 2003, p1).
DMT is used with a range of different client groups in a number
of different settings including health services, schools, social ser-
vices, voluntary organisations and prisons. Both individual (one
to one) as well as group work can take place. DMT as it is prac-
tised in the 21st century can be traced back to several pioneers
including Marian Chace (Levy 1992), an American dancer who
developed methods still in widespread use today. Aspects of prac-
tice developed by her include the use of a circular formation in
group DMT and active mirroring of movement, both of which
are associated with the development of the non-verbal therapeu-
tic relationship. However, there were also pioneers in other coun-
tries who developed their approaches initially independently of
American influences (Meekums 2008). Meekums 2008 suggests
that what marks out contemporary DMT practice is the empha-
sis on it as a form of psychotherapy. For many therapists, theo-
ries relating to psychoanalytic and psychodynamic principles are
used to guide practice (Karkou 2006). For example, the practice
of ’Authentic Movement’ (Whitehouse 1979) is associated with
Jungian psychology. For others, humanistic, developmental, be-
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havioural or eclectic and integrative models are valued (Karkou
2006). Meekums 1991, for example, in her work with mothers
and young children used a behaviourist approach combined with
attachment theory. More recently, Meekums 2002 suggested an
integrative framework based on the symbolic power of the ’move-
ment metaphor’, which transcends such theoretical divisions.
DMT has been posited as an appropriate intervention for patients
with a range of diagnoses andpresentingproblems, including those
for whom words may be difficult either because of cognitive im-
pairment or because the emotions being explored and expressed
are too painful. Sessions vary from 30 to 90 min and often take
place on a weekly basis at an agreed place and time. Interventions
may last from a few weeks to several months depending on client
needs. Both individual and one to one work can be provided.
How the intervention might work
For clients faced with depression or depressive symptoms, dance
movement therapy may have positive effects for a number of rea-
sons. For example, mood may be elevated because the use of dance
movement has an element of exercise (albeit often rather gentle)
for which there is already evidence of an impact upon depressive
symptoms, as reported in the exercise research literature (Mead
2010; NICE 2010). Many forms of DMT also involve the use of
music. An existing Cochrane review of music therapy (Maratos
2008) suggests possible benefit, although it cannot be assumed
that when music is used as part of another kind of therapy this
finding will still be valid as music therapy uses music in a very spe-
cific way. Reviews of verbal psychological therapies indicate that
there are benefits from the use of short-term psychodynamic psy-
chotherapy for common mental health problems (Abbass 2006),
psychotherapy for older people with depression (Wilson 2008)
and psychosocial and psychological interventions for antenatal
and postpartum depression (Dennis 2007a; Dennis 2007b). Since
dance movement therapists often draw upon psychotherapeutic
theoretical frameworks for their practice, these reviews might be
relevant. However, none of the above address the unique features
of DMT that may be responsible for any therapeutic effects on
people with depression.
Some of the specific effects of DMT can be attributed to the use
of non-verbal communication and kinaesthetic empathy in par-
ticular (Brooks 1989; Berrol 2006). Dance movement therapists
use a technique called ’mirroring’ as a way of achieving empathic
understanding and engaging patients. Some DMT literature (for
example Meekums 2002; Berrol 2006) discusses links between
DMTand studies in neuroscience (Rizzolatti 1996;Gazzola 2006)
and hypothesises that the effects of empathic engagement through
mirroring may be due to the activation of mirror neurons in the
brain. However, while echoing of movement has long been asso-
ciated with empathy and positive feelings towards the other, in-
cluding in therapeutic interactions (for example Scheflen 1964),
the precise role of mirror neurones in empathic engagement is not
identified. In addition, embodiment, creativity, movement-based
imagination, the use of symbolic movement and the use of move-
ment as a metaphor may be some of the unique features of DMT
responsible for specific effects on therapeutic change, as argued
by Karkou 2006. For example, as early as in 1981 Dosamantes-
Alperson argued for the value of activating imagination through
movement in DMT (Dosamantes-Alperson 1981). Working cre-
atively through movement may enable participants to engage in a
symbolic exploration that in turn may change cognitions and feel-
ings, as suggested by Meekums 2002. Meekums 2002 also argues
that ’movementmetaphor’ is another useful device as it serves both
to decrease emotional distance between the therapist and client or
patient and to increase emotional distance from distressing mem-
ories and feelings.
Finally, the embodied nature of DMT makes it potentially rele-
vant to those clients for whom body image or body memory may
be a particular issue requiring exploration and working through
(Meekums 2002). However, Heimbeck 2011 studied the effec-
tiveness of two different forms of movement therapy with depres-
sive patients (n = 103, Beck Depression Inventory (BDI) > 18)
where one was disorder specific and the other was non-specific to
the disorder. Both forms were effective and the authors concluded
that general disorder non-specific (though potentially specific to
DMT as in the examples given above) determinants play a more
important role in therapeutic success than assumed so far.
Why it is important to do this review
There have been very few systematic reviews of evidence concern-
ing DMT. A Cochrane review of DMT for schizophrenia (Xia
2010) found only one study that was of a sufficiently high quality
to include (Rohricht 2006). This study demonstrated a 20% re-
duction in negative symptoms such as social withdrawal, apathy,
inability to experience pleasure and defects in attention control;
symptoms that are closely linked with those of depression. The
Cochrane review protocol on DMT for cancer care (Bradt 2010)
also refers to the possible effects of participation in DMT sessions
upon reduction of isolation and depression (Dibbell-Hope 2000;
Mannheim 2006). However, none of these reviews have specifi-
cally focused on DMT for depression. An initial scoping review
of the literature, which searched for studies using the key words
’dance movement therapy’ and ’depression’ (Mala 2011 submitted
for peer review), suggests that there is some empirical research con-
cerning the effectiveness of DMT for depression. However, since
the search focused on electronic databases accessible through one
University’s licence only (that is Queen Margaret University) it is
likely that more studies may be revealed through a more extensive
search.
Once the current review is completed, it is expected that its
findings will further our understanding of research evidence in
DMT beyond schizophrenia (Xia 2010) and cancer care (Bradt
2010). CCDAN is currently working on other systematic reviews
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that address psychological therapies for depression (Hunot 2010;
Churchill 2010), and this review will therefore add to a grow-
ing bank of evidence in the treatment of depression. It will also
add to completed reviews relating to this client group, in music
therapy (Maratos 2008), exercise (Mead 2010) and psychother-
apy (Abbass 2006; Dennis 2007a; Dennis 2007b; Henken 2007;
Wilson 2008).
O B J E C T I V E S
1. To assess the effects of dance movement therapy (DMT) for
depression compared with no treatment (waiting list) or to
standard care in both child and adult populations
2. To compare DMT with other psychological interventions
(e.g. psychodynamic psychotherapy or IPT, counselling or CBT)
3. To compare DMT with pharmacological interventions (e.g.
anti-depressants, minor tranquillisers or mood stabilisers)
4. To compare DMT with other physical interventions (e.g.
dance or exercise)
5. To compare different forms of DMT (e.g. Laban-based
DMT, Chacian DMT or Authentic Movement) (see below for
explanations of these)
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials (RCTs), whether published or
unpublished and in any language, will be eligible for entry. Since
we will be working in an area where there is very little evidence to
date (as indicated by the scoping review performed byMala 2011,
submitted for peer review), cross-over designs will be considered,
up to the point of cross-over. . Cluster RCTs will be considered
using best practice. We will also consider trials for which there is
an evident clustering effect, for example individual randomisation
but to the same therapist. In this case we will reduce to an ’effective
sample size’ as suggested in section 16.3.4 and 16.3.5 of Higgins
2011. Trials with quasi-randomisation or systematic methods of
allocation (for example alternate allocation of treatments) will also
be eligible for inclusion. The rationale for this decision is that
historically DMT has been an under-funded area of study and so
large scale RCTs have sometimes been supplemented with more
pragmatic designs.
Types of participants
Participants will be those with symptoms of depression as de-
fined by the trialist. This may be defined clinically following ei-
ther the International Statistical Classification of Diseases and Re-
lated Health Problems (ICD)-10 (WHO 2010b) or Diagnostic
and Statistical Manual of Mental Disorders DSM-IV-TR (APA
2000) research diagnostic criteria or using a standardized measure
and scoring above the cut-off point on self-rated or clinician-rated
valid and reliable scales, for example the Beck Depression Inven-
tory (Beck 1961), the Symptom Check List-90-Revision (SCL-
90-R) (Derogatis 1977) or the Hamilton Rating Scale for Depres-
sion (HRSD) (Hamilton 1960). Cut-off scores will be those the
authors of these scales have defined as such. This criterion should
be present at the start of the trial. We will exclude trials involv-
ing participants with chronic or treatment resistant depression,
or participants at risk of relapse. We will also exclude studies in
which the primary diagnosis is either a physical condition or other
psychiatric diagnosis with depression secondary, though we will
include studies where there is a comorbid physical or common
mental disorder so long as these are secondary to the diagnosis of
depression. There will be no restrictions in terms of age, gender
or ethnicity nor in severity of depression. Both in-patients and
out-patients will be considered and in all settings including both
statutory and non-statutory organisations.
Types of interventions
Experimental intervention
For an intervention to be considered, it will have to include active
involvement of participants in dance movement in the presence
of a therapist or dance movement interaction with a therapist or
other group members, or both. Dance movement may be either
improvisatory or structured, with or without music. In all cases,
however, sessions will have to have a clearly articulated therapeutic
intent. The interventionwill need to be facilitated by a practitioner
who may have received formal training, be a dance movement
therapist in training, or be otherwise accredited in the country in
which the study was conducted.
Wewill include both group and individualDMTwithin any num-
ber and duration of sessions.
There are a number of different approaches toDMT.Karkou 2006
identifies three models, as follows.
(i) Some practitioners rely primarily upon dance movement en-
gagement, e.g. creative movement work primarily informed by an
early proponent of therapeutic applications of dance movement,
Rudolf Laban (Laban 1975), in order to explore specific move-
ment themes and qualities.
(ii) There are those that value the non-verbal interaction between
client(s) and therapist (interactive work based on principles devel-
oped originally by the American dance movement therapy pioneer
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Marion Chace, as described by Chaiklin 1986). In this approach,
the therapist (and at times other group members) actively mirrors
the movement of patients or clients.
(iii) Others encourage internal work in the presence of a therapist,
such as Authentic Movement which originated with the Ameri-
can choreographer Mary Whitehouse (Whitehouse 1979) and is
influenced by Jungian psychology. In Authentic Movement the
therapist stays still and observes, using self as an empathic witness.
In all cases, however, dance movement is used within a well-de-
fined therapeutic relationship, that is a relationship between the
client and therapist with or without others, for example group
members, with therapeutic intent. The therapist may be active
(moving with participants, as in the Chacian approach) or adopt
a more observational stance (as in Authentic Movement). In all
cases this involves an embodied empathic relationship. In addition
to this empathic engagement, the therapist’s body may be avail-
able for dynamic projections that can be worked through on either
the non-verbal or verbal level. Verbal reflection on the individual
meanings associated with movement may form an integral part of
DMT sessions. Studies of dance classes in which no therapeutic
relationship or psychotherapeutic intent is identified will be ex-
cluded.
Comparators
1. No treatment and standard care
The review will include all studies in which any form of DMT
is compared with no treatment or standard care. In the case of
no treatment, studies included may compare DMT with people
either recruited from the community or placed on waiting lists
and thus not receiving standard care. Studies where standard care
as defined by the trialists is available will also be considered along
with DMT or as a control.
2. Psychological therapies
Psychological therapies such as counselling, verbal psychothera-
pies including psychodynamic psychotherapy, IPT or CBT will
be considered as appropriate controls for either DMT alone or in
combination with standard care.
3. Pharmacological interventions
Studies that compare DMT with anti-depressant medication such
as SSRIs, Tricyclics, MAOIs and SNRIs will be included. Other
minor tranquillisers such as benzodiazepines and mood stabilisers
such as Lithium will also be considered, if relevant.
4. Physical interventions
Studies that compare DMT with physical interventions such as
exercise or dance will be considered.
5. Different types of DMT
Different types of DMT, as defined above, will be considered as
potential comparators.
Types of outcome measures
Primary outcomes
The primary outcomes will be level of depression as measured
through a valid and reliable scale or self-rated measurement such
as, but not limited to, the BeckDepression Inventory (Beck 1961),
the Symptom Check List-90-Revision (SCL-90-R) (Derogatis
1977) or a clinician-rated scale such as the Hamilton Rating Scale
for Depression (HRSD) (Hamilton 1960). Continuous outcomes
of depression improvementwill be used; however, where the trialist
has dichotomised outcomes we will also analyse these. We will
refer to the literature on the standardized measure used in order
to determine what is a minimal clinically significant change.
Drop-out rates will also be reported, as a measure of treatment
acceptability (high drop-out rates being seen as a measure of po-
tential harm because they suggest unacceptability).
Secondary outcomes
We will report the following secondary outcomes.
1. Social and occupational functioning (e.g. engagement in
social activities (Tyrer 2005)).
2. Quality of life (e.g. WHOQOL-BREF (WHO 2004)).
3. Self esteem (e.g. Rosenberg 1965).
4. Body image (e.g. the Body Image Quality of Life Inventory
(Cash 2002)).
5. Cost effectiveness of treatment, as measured by the trialist.
In all cases, validated measurements will be preferred over non-
validated measurements, especially when different measurements
were used for the same outcome. It is expected that outcomes will
be measured at various time points, as follows:
1. End of intervention.
2. Short-term follow up (up and including three months after
intervention end)
3. Medium-term follow up (more than three months, and up to
and including 6 months after intervention end)
4. Long-term follow up (more than six months after intervention
end)
Adverse events
The authors plan to summarise adverse events quantitatively or
qualitatively depending on the information available in trial re-
ports. This could include, for example, a worsening of symptoms
as identified using the measures identified above, or injury.
Search methods for identification of studies
The CCDAN Specialized Register (CCDANCTR)
The Cochrane Depression, Anxiety and Neurosis Group (CC-
DAN)maintain two clinical trials registers at their editorial base in
Bristol, UK, a references register and a studies based register. The
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CCDANCTR-References Register contains over 28,000 reports
of trials in depression, anxiety and neurosis. Approximately 65%
of these references have been tagged to individual, coded trials.
The coded trials are held in the CCDANCTR-Studies Register
and records are linked between the two registers through the use
of unique study identity (ID) tags. Coding of trials is based on the
EU-Psi coding manual. Please contact the CCDAN Trials Search
Coordinator for further details.
Reports of trials for inclusion in the Group’s registers are col-
lated from routine (weekly) generic searches of MEDLINE (1950
on), EMBASE (1974 on) and PsycINFO (1967 on); quarterly
searches of the Cochrane Central Register of Controlled Trials
(CENTRAL); and review specific searches of additional databases.
Reports of trials are also sourced from international trials regis-
ters through the World Health Organization’s trials portal (IC-
TRP), drug companies, the handsearching of key journals, con-
ference proceedings and other (non-Cochrane) systematic reviews
and meta-analyses. Details of CCDAN’s generic search strategies
can be found on the Group‘s website.
Electronic searches
The CCDANCTR-Studies Register will be searched by the Trials
Search Coordinator (TSC) using the following terms: Condition
= (depress* or dysthymi*) AND Intervention = “dance therapy”.
The CCDANCTR-References Register will be searched by the
TSC using a more sensitive set of free-text terms:
(depress* or dysthymi* or “adjustment disorder*” or “mood disor-
der” or “affective disorder*” or “affective symptom*” )AND(danc*
or “authentic movement*” or “movement therap*” or “movement
psychotherap*” or “body psychot*”).
We will conduct complementary searches on AMED, CINAHL,
ERIC, Dissertation Abstracts, the WHO trials portal (ICTRP)
and ClinicalTrials.gov.
Searching other resources
In an effort to identify further published, unpublished and ongo-
ing trials we will:
• search the bibliographies of relevant studies and reviews;
• contact the professional associations and educational
programmes in dance movement therapy from around the world
including those in the UK, USA, Australia, Europe, Israel, Korea
and Japan, asking members to inform us about published and
unpublished research studies including Masters and PhD work
that meet the inclusion criteria;
• contact experts in the field.
Data collection and analysis
Selection of studies
Two members of the team (BM, VK) will screen titles and ab-
stracts of all studies, where available, for inclusion according to the
inclusion criteria identified above (Criteria for considering studies
for this review) and below (Data extraction and management).
We will use a proforma based on these criteria to assess the trial’s
eligibility for inclusion (see Appendix 1). From these, the same
two review authors will obtain full reports for trials appearing to
meet the inclusion criteria and for which there is insufficient in-
formation in the title and abstract to make a clear decision.
Two review authors (BM, VK) will each independently assess full
reports to establish whether the trial meets the inclusion criteria or
not. We will resolve disagreements by discussion; where this does
not result in agreement a third member of the review team (AN)
will arbitrate. If we exclude a trial after the abstract stage, we will
keep a record of both the article and the reason for exclusion.
Data extraction and management
Two review authors (BM, VK) will each independently extract
data using a specially designed data extraction form (See Appendix
1). We will resolve disagreements by discussion; where this does
not result in agreement a third member of the review team (AN)
will arbitrate. In the first instance, we will extract data relating to
the following categories.
1. General information.
2. Eligibility criteria. (An interim decision will be recorded as
follows: inclusion, exclusion or requiring more information from
the authors. The final decision will then be recorded, after
inclusion of additional information obtained. In this second
stage we will extract the following information as detailed in the
sample data extraction form presented in Appendix 1.)
3. Study characteristics.
4. Interventions.
5. Outcome measures used in the study.
6. Study results.
7. Additional notes.
Main comparisons
We plan to make the following treatment comparisons.
1. DMT versus no treatment (waiting list) and DMT plus
standard care versus standard care.
2. DMT versus other psychological interventions (e.g.
psychodynamic psychotherapy, IPT or CBT).
3. DMT versus pharmacological interventions (e.g. anti-
depressants, minor tranquillisers and mood stabilisers).
4. DMT versus other physical interventions (e.g. dance or
exercise).
5. One form of DMT versus another (e.g. Laban-based DMT
versus Chacian DMT or Chacian DMT versus Authentic
Movement).
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Assessment of risk of bias in included studies
Two review authors (BM, VK) will each independently conduct a
’risk of bias’ assessment. We will solve any disagreements through
discussion. The review authors will record a judgement of ’low
risk’, ’high risk’ or ’unclear risk’ of bias for each of six domains,
using a proforma designed for this purpose (see Appendix 1) (
Higgins 2011).
Low, high and unclear risk will be identified for the
following as defined in Appendix 1:
1. Selection bias
a) Random sequence generation
b) Allocation concealment
2. Blinding of participants and personnel
3. Blinding of outcome assessment
4. Intention-to-treat analysis (ITT) for continuous outcomes
5. Outcome reporting bias
6. Other sources of bias
We will not exclude studies based on a high risk of bias.
Measures of treatment effect
The levels of depression will be measured using rating scales pre-
sented as dichotomous or continuous outcomes. We will sum-
marise dichotomous outcomes, such as the number of people
achieving aminimumclinically significant reduction in level of de-
pression, using odds ratios (OR). For continuous outcomes, such
as scores from a scale and they come from the same scale, we will
use mean differences (MD). When outcomes from different scales
are combined, we will use standardized mean differences (SMD).
We will calculate 95% confidence intervals (CI) for each effect
estimate. If sufficient data are available to pool both dichotomous
and continuous outcomes, we will do so using the formula rec-
ommended in section 9.4.6 of Higgins 2011.
Two review authors (AN, BM) will perform a meta-analysis on
the extracted data if:
• more than one study is included with an estimated
treatment effect;
• there are minimal differences in characteristics across
studies, or these characteristics have been identified a priori and
investigated as a potential source of heterogeneity in subgroup
analyses;
• the same outcomes have been measured using validated
scales;
• data in each study are available.
If different scales have been used to measure the same outcome,
data will be entered into RevMan to summarise outcomes across
scales using the standardized mean difference. It is expected that
studies will have used different time points for measurement. If
sufficient data are available, the authors plan to conduct a meta-
analysis with planned subgroup analysis to look at different time
points: short follow-up (up to 14 weeks); moderate follow-up (15
to 27 weeks) and long follow-up (28 weeks and over). If there
are marked variations in the interventions offered, the popula-
tions studied and the outcome measures used, the review will be
restricted to developing a narrative description of the findings of
individual trials. In all cases, we will consider the objectives of the
review in terms of (i) identifying evidence relating to the efficacy
of dance movement therapy for depression on its own, (ii) com-
parison with standard care or other treatments, and (iii) when dif-
ferent types of dance movement therapy are used.
Unit of analysis issues
We will include cross-over trials, only using the first active treat-
ment period. For studies with multiple arms, only those with
DMT and the control will be included in the analysis. If there are
two DMT arms with a single control group (for example a dose
study), then prior to the meta-analysis we will halve the effective
sample size of the control in order to avoid counting the same
participants twice.
In the case of cluster randomisation, we will conduct the analysis
at the same level as the allocation, using a summary measurement
from each cluster. The sample size will then be treated as the
number of clusters in order to avoid unit-of-analysis errors.
Dealing with missing data
Where individuals are missing from end of treatment scores, we
will contact the trialist in the first instance in an attempt to obtain
themissing data and the reason for this. If data are unavailable and
unlikely to be ’missing at random’ (Higgins 2011, 16.1.2), and
provided that the individuals concerned did receive the interven-
tion to which they were allocated, we will assume that the individ-
uals have dropped out from the treatment, which offers some in-
dication of its acceptability (calculated as a percentage drop-out).
Where standard deviations (SD) are unavailable, we will in the
first instance look for other reported measures that will allow us
to impute the standard deviation (for example, p values, t values,
confidence intervals and standard errors). If sufficient numbers of
studies are available to allow us to impute a SD,we will do so either
by taking the mean or (if fewer than six studies are available for
this or there is considerable variability) we will assume the highest
value. This will be noted, however, as it may bias towards lack
of effect. Sensitivity analyses will be performed for all imputed
measures.
Where authors describe an intention to treat (ITT) analysis, we
will scrutinise the data and where necessary contact the authors
to determine whether this is in fact so, or whether a per-protocol
analysis has been performed (Higgins 2011, 16.2.1). Given that
ITT analyses tend to bias towards no difference (because they
include participants who are randomised to the treatment group
but in fact receive something else) an available case analysis will
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be performed in addition to an ITT analysis and we will carry out
a sensitivity analysis (Higgins 2011, 16.2.1).
For the ITT analysis, we will treat missing data cautiously, assum-
ing no change since the last available measurement (continuous
outcomes) or no change overall for dichotomous outcomes. This is
because in a depression trial, those individuals who do not attend
for their end of treatment measurements may have had a relapse of
their depression. Any analysis of the available data without adjust-
ment for this will be biased. We will therefore impute missing data
with replacement values, treating these as if they were observed by
carrying the last measurement forward.
All missing datawill be reported in the risk of bias tables (Appendix
1).
Assessment of heterogeneity
Initially, the review authors will inspect studies to identify sources
of clinical heterogeneity; studies will only be pooled if there is
sufficient clinical homogeneity. In order to assess this, tables will
be constructed to summarise studies in terms of participants, set-
tings, method of delivery (that is group or individual, number of
sessions), type of dance movement therapy used, and outcomes
presented. If the identified studies appear to be clinically similar,
two review authors (AN, BM) will undertake a further analysis of
statistical heterogeneity. Heterogeneity will initially be identified
visually (if confidence intervals are not overlapping, this indicates
heterogeneity). If appropriate, the Chi2 test will be applied. If Chi
2 is greater than the degrees of freedom (which is one less than
the number of studies in the forest plot) then heterogeneity is
present. Given that some statistical heterogeneity is inevitable, the
I2 statistic (Higgins 2002) will also be applied in order to assess
its impact on the meta-analysis (Higgins 2011, 9.5.2), using over-
lapping bands as follows:
• I2 = 0% to 40%: might not be important
• I2 = 30% to 60%: may represent moderate heterogeneity
• I2 = 50% to 90%: may represent substantial heterogeneity
• I2 = 75% to 100%: considerable heterogeneity
Despite these figures, for psychological assessments it may be ac-
ceptable to pool studies with up to 80% heterogeneity. However,
low quality studies will then be removed and a sensitivity analysis
performed.
Assessment of reporting biases
Where evidence of missing outcomes is found, attempts will be
made to obtain available data direct from the trial authors. We will
consider the studies for reporting biases, including whether only
positive results were published and whether they were published
more rapidly. We will also consider whether English publications
included more positive results than those in other languages, and
we will consider citation bias and outcome reporting bias. We will
use a funnel plot analysis to examine publication bias if there are
more than 10 studies addressing a particular question.
Data synthesis
We will enter all trials included in the systematic review into Re-
view Manager (Revman 5.1).
If the formal test of homogeneity shows that there is significant
heterogeneity (see Assessment of heterogeneity) which is not due
to a moderator variable, we will use random-effects models to
calculate differences between treatment and control groups and
pooled estimates.
Subgroup analysis and investigation of heterogeneity
If possible, we will perform subgroup analyses by:
• mode of delivery including group or individual;
• moving or non-moving therapist;
• length of treatment including number of sessions (session
number of fewer than 12, 12 and more);
• intensity of intervention, to include frequency (weekly or
less frequent, bi-weekly or more frequent) and duration of
sessions (one hour or less, more than one hour);
• severity of depression at start of treatment (mild, moderate
or severe, as identified by the trialist using standardized
measures);
• participant characteristics including gender (men, women
or other) and age (under 18 years or child and adolescent
however determined by the trialist, 18 to 64 years or adult
however determined by the trialist, 65 years and over or older
adult however determined by the trialist);
• setting (statutory and non-statutory).
Sensitivity analysis
We will perform a sensitivity analysis, if relevant, in order to test
methodological decisions made throughout the review process:
1. Different designs:
• a) Quasi-RCTs (with systematic methods of allocation)
• b) Cross-over designs
• c) Cluster RCTs and other cluster effects including
randomisation but to the same therapist.
2. High risk of bias, for example due to poor allocation conceal-
ment.
3. Imputed measures vs available case analysis.
4. Other identified low quality studies.
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A P P E N D I C E S
Appendix 1. Sample of data extraction form
Data Extraction for all Relevant Studies
General information
• ’Data extractor’/author ID: ............................................................
• Date of extraction: .......................................................................
• Study ID: .....................................................................................
• Title, author/s, publication details of study:
..........................................................................................................................................................
• Source if unpublished:
.........................................................................................................................................................................................
• language of publication: ......................................................
Eligibility criteria
Does the study meet the inclusion criteria, and how?
• Study design (parallel, controlled trial, randomised controlled trial):
...............................................................................................................
• Participants (diagnosis of depression, valid and reliable depression scores or symptom measures):
........................................................................................................................................................................................................................
• Interventions (type of dance movement therapy):
.......................................................................................................................................................................................................................
• Outcomes (changes in scores of depression and depressive symptoms:
.......................................................................................................................................................................................................................
Inclusion ? Exclusion ? More Information Needed ?
Data Extraction for Included Studies
Study characteristics
• Study setting (e.g. country, urban/rural, hospital/clinic/school/charity/community/prison etc:
.....................................................................................................................................................
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• Participant demographics (e.g. age, gender, socio-economic status, co-morbidity):
....................................................................................................................................................
..
• Inclusion/exclusion criteria used in the study:
...............................................................................................................................................................
Outcome measures used in the study
• Primary outcome measures that provide scores for:
1. Depression as measured using valid and reliable scale measurements
......................................................................................................................................................................................................................................
1. Depressive symptoms including: low mood; fatigue; sleep disturbance; appetite disturbance; suicidal ideation
.........................................................................................................................................................................................................................................
• Secondary outcome measures that provide scores for:
1. Social and occupational functioning, (e.g. engagement in social activities)
........................................................................................................................................................................................................................................
1. Quality of life
.........................................................................................................................................................................................................................................
1. Self esteem and body image
........................................................................................................................................................................................................................................
1. Adverse effects (including injury, suicide or suicide attempt/s)
......................................................................................................................................................................................................................................
1. Overall treatment dropouts
.....................................................................................................................................................................................................................................
1. Costs
....................................................................................................................................................................................................................................
Study results
• Source (table, graph, text) ..............................................................................................................
• Participants, number of events, percentages, chi-squares, risk ratios, for dichotomous outcomes, mean differences or
standardized mean differences for continuous outcomes, missing participants
.....................................................................................................
.....................................................................................................
• Queries regarding data or methods (to be referred to the author for further information)
.................................................................................................................................................
Additional notes
• Record of details regarding correspondence with author/s for additional information or clarification of queries
.......................................................................................................................................................
• Ethics of stated conflict of interest ....................................................................................................
• Details of other studies cited in the references ................................................................................
• Duplicate publications .....................................................................................................................
• Translation required .......................................................................................................................
Risk of bias assessment
1. Selection bias
a)Method of randomisation
Was the trial reported as randomised? YES/NO/UNCLEAR
Was the method of randomisation appropriate? YES/NO/UNCLEAR
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Randomization will be rated as appropriate if every participant had equal chance to be selected for either condition and if investigator
was unable to predict which treatment the participant would be assigned to. Examples are: random number table; computer random
number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing lots; minimization.
Inappropriate methods include: use of date of birth; sequence generated by a rule e.g. date of admission; patient preference; clinician
judgement; availability of the intervention.
Unclear: insufficient information on which to base judgement.
b) Allocation concealment
Was allocation concealment adequate? YES/NO/UNCLEAR
Adequate - methods to conceal allocation include: central allocation (e.g. telephone, web or pharmacy based randomisation); serially
numbered, opaque, sealed envelopes; other descriptions with convincing concealment
Inadequatemethods include: open random allocation schedule, e.g. list of randomnumbers; envelopes without safeguards, e.g. unsealed,
non-opaque or not sequentially numbered; alternation or rotation; date of birth; case record number; any other explicitly unconcealed
procedure.
Unclear: authors did not adequately report on method of concealment
2. Blinding of participants and personnel
Was the discussion of participant and personnel blinding adequate? YES/NO/UNCLEAR
NB For dance movement therapy studies, it is not possible to blind participants and those providing the dance movement therapy
interventions. Adequate discussion of blinding would therefore be implied in adequate randomisation and allocation concealment (see
above).
Inadequate blinding would be implied in studies for example in which the therapist, participant and/or researcher chooses participants
for the experimental group.
Unclear blinding would be implied in cases in which either allocation concealment or randomisation are unclear.
3. Blinding of outcome assessment
Was discussion of blinding of outcome assessment adequate? YES/NO/UNCLEAR
NB A yes is possible if blinding of outcome assessment is not ensured (both blinded and unlikely to be broken), but that the review
authors judge this is unlikely to influence outcome measurement.
A judgement of unclear will be used if the study does not address this.
4. Intention-to-treat analysis
Was ITT analysis adequate? YES/NO/UNCLEAR
An intention-to-treat ( ITT) analysis will be considered adequate when: there are no missing outcome data; reasons for missing data
unlikely to be related to true outcome; missing outcome data are balanced across comparison groups, with similar reasons; plausible
effect size (difference in means or standardized difference in means) among missing outcomes is insufficient to have clinically relevant
impact on observed effect size; missing data are imputed using appropriate methods.
Inadequate: reasons for missing outcome data likely to be related to true outcome, with either imbalance of numbers or reasons
for missing data across groups; plausible effect size among missing outcomes sufficient to induce clinically relevant bias in observed
effect size; ’as treated’ analysis performed with substantial departure of the intervention received from that assigned at randomisation;
potentially inappropriate application of simple imputation.
Unclear: insufficient reporting of attrition or exclusions to permit judgement, e.g. number randomisation not stated or no reasons for
missing data given; or the study did not address this outcome.
5. Outcome reporting bias
Was the reporting bias acceptable? YES/NO/UNCLEAR
Reporting bias will be assessed as acceptable if: the study protocol is available and all pre-specified outcomes of interest in the review
have been reported in the pre-specified way; or the protocol is not available but it is clear that the published reports include all expected
outcomes.
Unacceptable: not all of the pre-specified primary outcomes are reported; one or more of these is reported using measurements or
analytic methods or subsets of data that were not pre-specified; one or more of the primary outcomes were not pre-specified (unless
clearly justified, e.g. adverse effect); one of more outcome of interest is reported incompletely and so cannot be entered into meta-
analysis; failure to report results for a key outcome that would be expected from such a study (including adverse outcomes).
Unclear: insufficient information to make a judgement.
6. Other sources of bias
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Were other sources of bias eliminated: YES/NO/UNCLEAR
Examples of other risk of bias include: those related to study design; claimed to be fraudulent.
Examples of unclear risk of bias include: insufficient rationale or evidence that an identified problem would introduce bias.
The above criteria will be used to give each article an overall quality rating, as follows:
A. Low risk of bias - all criteria met.
B. Moderate risk of bias - one or more of the criteria only partly met.
C. High risk of bias - one or more criteria not met.
Studies will not be excluded based on a low quality score.
H I S T O R Y
Protocol first published: Issue 6, 2012
C O N T R I B U T I O N S O F A U T H O R S
Draft the protocol: BM, VK and AN. Develop search strategy and undertake searches: VK and BM in consultation with the CCDAN
Trials Search Co-ordinator. Data extraction and management: BM and VK. Assessment of quality: BM, VK and AN. Analysis and
synthesis: statistical, AN and BM; narrative, BM and VK.
D E C L A R A T I O N S O F I N T E R E S T
Both Karkou and Meekums are members of the Association for Dance Movement Psychotherapy UK (ADMP UK). Both have
completed studies that may be included in the review.
S O U R C E S O F S U P P O R T
Internal sources
• University of Leeds, School of Healthcare, UK.
Provided computer / email resources and time for Meekums and Nelson to work on review.
• Queen Margaret University, School of Health Sciences, UK.
Provided computer/email resources and time for Karkou to work on review. Offered access to electronic databases for Mala to work
on scoping review
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External sources
• No sources of support supplied
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